VIVEbiotech, S.L., a gene transfer technologies CDMO developing and manufacturing lentiviral vectors, is opening new facilities for the manufacture of lentiviral vectors for the cell and gene therapy sector. The facility will be capable of manufacturing batches ranging from those for early stage research to GMP for clinical and future commercial uses.   The expanded facilities will allow the company to significantly increase its production capacity and deliver commercial-size batches of lentiv...